Publications in collaboration with researchers from Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (78)

2024

  1. Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes

    DIABETES THERAPY, Vol. 15, Núm. 5, pp. 1069-1084

  2. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

    Molecular Metabolism, Vol. 79

  3. Inhibition of hepatic p63 ameliorates steatohepatitis with fibrosis in mice

    Molecular Metabolism, Vol. 85

  4. Localization, traffic and function of Rab34 in adipocyte lipid and endocrine functions

    Journal of Biomedical Science, Vol. 31, Núm. 1

  5. Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway

    Cell Reports Medicine, Vol. 5, Núm. 7

  6. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  7. Remodeling p38 signaling in muscle controls locomotor activity via IL-15

    Science advances, Vol. 10, Núm. 33, pp. eadn5993

  8. Tanycytic transcytosis inhibition disrupts energy balance, glucose homeostasis and cognitive function in male mice

    Molecular Metabolism, Vol. 87

  9. The effects of ghrelin and LEAP-2 in energy homeostasis are modulated by thermoneutrality, high-fat diet and aging

    Journal of Endocrinological Investigation, Vol. 47, Núm. 8, pp. 2061-2074

  10. The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis

    Metabolism: Clinical and Experimental, Vol. 158

  11. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

    Cell Reports Medicine, Vol. 5, Núm. 2